Match!
Stephanie Harvard
University of British Columbia
16Publications
5H-index
65Citations
Publications 16
Newest
#1Stephanie Harvard (UBC: University of British Columbia)H-Index: 5
#2Daphne GuhH-Index: 26
Last.Aslam H. Anis (UBC: University of British Columbia)H-Index: 55
view all 7 authors...
Background Anti-tumor necrosis factor (anti-TNF) agents are an effective, but costly, treatment for spondyloarthritis (SpA). Worldwide, multiple sets of access criteria aim to restrict anti-TNF therapy to patients with specific clinical characteristics, yet the influence of access criteria on anti-TNF cost-effectiveness is unknown. Our objective was to use data from the DESIR cohort, a prospective study of early SpA patients in France, to determine whether the French anti-TNF access criteria are...
#1Carlo A. Marra (University of Otago)H-Index: 47
#2Stephanie Harvard (UBC: University of British Columbia)H-Index: 5
Last.Larry D. Lynd (UBC: University of British Columbia)H-Index: 28
view all 7 authors...
Food allergen labeling is an important tool to reduce risk of exposure and prevent anaphylaxis for individuals with food allergies. Health Canada released a Canadian food allergen labeling regulation (2008) and subsequent update (2012) suggesting that research is needed to guide further iterations of the regulation to improve food allergen labeling and reduce risk of exposure. The primary objective of this study was to examine consumer preferences in food labeling for allergy avoidance and anaph...
#1Stephanie Harvard (UBC: University of British Columbia)H-Index: 5
#2Daphne GuhH-Index: 26
Last.Aslam H. AnisH-Index: 55
view all 7 authors...
Objective To evaluate a classification system to define adherence to axial spondyloarthritis (axSpA) anti-tumor necrosis factor (anti-TNF) use recommendations and examine the effect of adherence on outcomes in the DESIR cohort (Devenir des Spondylarthropathies Indifferenciees Recentes). Methods Using alternate definitions of adherence, patients were classified as adherent “timely” anti-TNF users, nonadherent “late” anti-TNF users, adherent nonusers (“no anti-TNF need”), nonadherent nonusers (“un...
#1Stephanie Harvard (UBC: University of British Columbia)H-Index: 5
#2Daphne GuhH-Index: 26
Last.Bruno Fautrel (University of Paris)H-Index: 14
view all 7 authors...
Objectives: To value health resource utilisation and productivity losses in DESIR, a longitudinal French cohort of 708 patients with early spondyloarthritis (SpA) enrolled between 2007 and 2010, and identify factors associated with costs in the first 3 years of follow-up. Methods: Self-reported clinical data from DESIR and French public data were used to value health resource utilisation and productivity losses in 2013 Euros. Factors associated with costs, including and excluding biological drug...
#1Stephanie Harvard (University of Paris)H-Index: 5
#2Laure Gossec (University of Paris)H-Index: 55
Last.Bruno Fautrel (University of Paris)H-Index: 14
view all 7 authors...
Joint Bone Spine - In Press.Proof corrected by the author Available online since samedi 14 mars 2015
#1Stephanie HarvardH-Index: 5
#2A. MoltoH-Index: 4
Last.Aslam H. AnisH-Index: 55
view all 9 authors...
Background We previously described the clinical effectiveness of TNFα blockers in a population of matched pairs within the DESIR cohort of early spondyloarthritis (SpA) patients.1 Health utilities and costs have not yet been compared among these patients. Objectives To compare costs and SF6D health utilities among SpA patients treated and not treated with TNFα blockers in the DESIR cohort. Methods The DESIR cohort includes 708 patients with early (<3 years) SpA symptoms who are followed-up every...
#1Stephanie HarvardH-Index: 5
#2Daphne GuhH-Index: 26
Last.Bruno FautrelH-Index: 25
view all 7 authors...
Background The costs of spondyloarthritis (SpA) from health resource use (HRU) and productivity loss (PL) have chiefly been evaluated among patients with established disease. Costs among early SpA patients have not been well described. Objectives To describe trends in HRU and PL costs over the first 3 years of the DESIR cohort of early SpA patients. Methods DESIR is a longitudinal cohort of 708 patients with early ( Results The analysis included 496 patients. By Year 3, 45% of patients satisfied...
In 2010, the Canadian province of Ontario passed regulations to prohibit pharmacy chains from selling their own "private label" (PL) generic drugs. Pharmacy chain owners Shoppers Drug Mart Corporation and Katz Group Canada challenged the regulations, stating they fell outside the purpose and authority of their overarching legislation that was meant to promote low drug prices. In 2013, the Supreme Court of Canada ruled in favor of the ban, prohibiting PL generic drugs in Ontario. However, the Sup...
It is estimated that 50% of Canadian households are directly or indirectly affected by food allergies. Since accidental exposure to food allergens can cause life-threatening reactions, the need for accurate allergen labelling is key. In Canada, new food allergen labelling guidelines were mandated in August 2012. While a substantial improvement, gaps remain. This study explored the perspectives of directly affected individuals as well as members of the general public regarding their needs and pre...
12